Timing of first-line cancer treatments – Early versus late – A systematic review of phase III randomized trials
- 31 December 2010
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 36 (8) , 621-628
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Treatment of chronic lymphocytic leukemia in early and stable phase of the disease: Long-term results of a randomized trialEuropean Journal of Haematology, 2009
- Barriers to fertility preservation among pediatric oncologistsPatient Education and Counseling, 2008
- American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer PatientsJournal of Clinical Oncology, 2006
- Immediate or Deferred Androgen Deprivation for Patients With Prostate Cancer Not Suitable for Local Treatment With Curative Intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891Journal of Clinical Oncology, 2006
- Reasonable Delay of Surgical Treatment in Men with Localized Prostate Cancer - Impact on Prognosis?European Urology, 2005
- Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical surveyBMJ, 2005
- Validity of composite end points in clinical trialsBMJ, 2005
- Chemotherapeutic Options in Chronic Lymphocytic Leukemia: a Meta-analysis of the Randomized TrialsJNCI: Journal of the National Cancer Institute, 1999
- Immediate Estrogen or Estramustine Phosphate Therapy Versus Deferred Endocrine Treatment in Nonmetastatic Prostate Cancer: A Randomized Multicenter Study With 15 Years of FollowupJournal of Urology, 1995
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986